Stock Market News

15 hours BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer Zacks

The European Commission approves Bristol Myers’ Opdivo plus Yervoy for first-line treatment of MSI-H or dMMR unresectable or metastatic colorectal cancer.

Bristol · Bristol-Myers Squibb (BMY)

5 days Bristol-Myers Squibb: Rich Dividends & Double-Digits Upside Potential – Bright 2026 Prospects Seeking Alpha

5 days Bristol-Myers Squibb Will Handle The Patent Cliff And Is Still Undervalued Seeking Alpha

5 days Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today Zacks

6 days Bristol Myers Squibb Stock Earns 83 RS Rating Investor's Business Daily

7 days Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know Zacks

7 days Bristol-Myers: Still An Opportunity Yielding Over 4% Seeking Alpha

1 week Jefferies Upgrades Bristol Myers Squibb to ‘buy’ on drug Cobenfy Investing.com

1 week BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks

2 weeks Bristol Myers Squibb (BMY) Stock Moves -0.89%: What You Should Know Zacks

2 weeks Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell? Zacks

2 weeks Bristol Myers (BMY) Upgraded to Buy: Here’s Why Zacks

2 weeks Is Bristol Myers Squibb (BMY) a Great Value Stock Right Now? Zacks

3 weeks Analyst Report: Bristol-Myers Squibb Co. Yahoo Finance

3 weeks Bristol-Myers Squibb Company (BMY) Citi’s 2024 Global Healthcare Conference (Transcript) Seeking Alpha

3 weeks Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know Zacks

3 weeks Is Bristol-Myers Squibb Stock a Millionaire Maker? Yahoo Finance

4 weeks Calls of the Day: Martin Marietta, Datadog, Bristol-Myers, Eli Lilly and Disney YouTube

4 weeks Prime Medicine’s Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies Seeking Alpha

4 weeks 5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade) Seeking Alpha

1 month AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback Investor's Business Daily

1 month Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug Zacks

1 month Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It Zacks

1 month Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript) Seeking Alpha

1 month Bristol-Myers Squibb: Buy This Bargain Before It’s Gone Seeking Alpha

1 month 3 Stocks Seeing Insider Buys: CNC, PFE, BMY Zacks

1 month Bristol-Myers Squibb Company (BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference (Transcript) Seeking Alpha

1 month Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell? Zacks

1 month Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’ Investor's Business Daily

2 months Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade Investor's Business Daily

2 months Bristol-Myers Tops Q3 Earnings and Sales Estimates, Ups 2024 EPS View Zacks

2 months Bristol Myers Screams To A Year-High After Walloping Profit Expectations Investor's Business Daily

2 months Pallas Capital Advisors LLC Purchases 9,537 Shares of Bristol-Myers Squibb (NYSE:BMY) MarketBeat

2 months Wealth Enhancement Advisory Services LLC Cuts Stake in Bristol-Myers Squibb (NYSE:BMY) MarketBeat

2 months Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings? Zacks

2 months Bristol-Myers Squibb Deserves Its Place Among Its Big Pharma Brethren Seeking Alpha

2 months Allspring Global Investments Holdings LLC Has $11.12 Million Stake in Bristol-Myers Squibb (NYSE:BMY) MarketBeat

2 months Bristol Myers Squibb’s Q3 Earnings Are Likely To Be Strong Seeking Alpha

2 months Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know Zacks

2 months Impact Partnership Wealth LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY) MarketBeat

2 months Leerink Partnrs Issues Pessimistic Forecast for BMY Earnings MarketBeat

2 months FY2028 Earnings Estimate for BMY Issued By Leerink Partnrs MarketBeat

2 months Sequoia Financial Advisors LLC Has $7.40 Million Position in Bristol-Myers Squibb (NYSE:BMY) MarketBeat

2 months Bristol Myers (BMY) Upgraded to Buy: Here’s What You Should Know Zacks

2 months BMY or VRTX: Which Is the Better Value Stock Right Now? Zacks

2 months Raleigh Capital Management Inc. Has $2.20 Million Holdings in Bristol-Myers Squibb (NYSE:BMY) MarketBeat

2 months Commonwealth Equity Services LLC Decreases Position in Bristol-Myers Squibb (NYSE:BMY) MarketBeat

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.